University-Industry Cooperation Group Of Kyung Hee University;Navipharm Co, Ltd
发明人:
KIM, Dong-Hyun,HAN, Myung Joo
申请号：
SG11201911984Q
公开号：
SG11201911984QA
申请日:
2018.09.28
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
The present invention relates to a novel lactic acid bacteria and, more particularly, to a composition useful for prevention or treatment of cranial nerve and mental disorder or inflammatory disease, comprising the novel lactic acid bacteria Lactobacillus reuteri NK33 KCCM12090P or Bifidobacterium adolescentis NK98 KCCM 12297P. In addition, the present invention relates to a composition for diagnosis of cranial nerve and mental disorders, comprising an agent for measuring a level of gut microorganisms, a kit comprising the same, and a method for diagnosis of cranial nerve and mental disorders, comprising a step of measuring a level of gut microorganisms.
